Cargando…

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study

Purpose A international registry analysis led by Mehra et al. to investigate the use of hydroxychloroquine (HCQ) and chloroquine (CQ) with or without a macrolide in 96,032 hospitalised COVID-19 patients were published on Lancet, which has raised considerable discussions in the public health communit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toumi, Mondher, Biernikiewicz, Malgorzata, Liang, Shuyao, Wang, Yitong, Qiu, Tingting, Han, Ru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733902/ https://www.ncbi.nlm.nih.gov/pubmed/33343837 http://dx.doi.org/10.1080/20016689.2020.1809236

Ejemplares similares

The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021)

Chinese guidelines related to novel coronavirus pneumonia
por: Qiu, Tingting, et al.
Publicado: (2020)

Characteristics of doctor-shoppers: a systematic literature review
por: Biernikiewicz, Małgorzata, et al.
Publicado: (2019)

Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers
por: Qiu, Tingting, et al.
Publicado: (2021)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

Rapid literature review: definition and methodology
por: Smela, Beata, et al.
Publicado: (2023)

Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment
por: Qiu, Tingting, et al.
Publicado: (2022)

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
por: Han, Ru, et al.
Publicado: (2021)

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
por: Pochopień, Michał, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis
por: Margas, Wojciech, et al.
Publicado: (2022)

Critical Analysis of Select Hospital Reports in the Lancet
Publicado: (1827)

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update
por: Han, Ru, et al.
Publicado: (2019)

The Lancet COVID-19 Commission
por: Sachs, Jeffrey D, et al.
Publicado: (2020)

Benefits of probabilistic sensitivity analysis – a review of NICE decisions
por: Adalsteinsson, Erpur, et al.
Publicado: (2013)

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)

Factors influencing the COVID-19 daily deaths' peak across European countries
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
por: White, Nicholas J., et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19 – A narrative review
por: Bajpai, Jyoti, et al.
Publicado: (2020)

Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Publicado: (2020)

The Lancet
Publicado: (1885)

On the Lancet
por: Osborne, T. C.
Publicado: (1881)

The Lancet
Publicado: (1861)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
por: Taccone, Fabio S, et al.
Publicado: (2020)

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

HYDROXYCHLOROQUINE AND COVID-19: A META-ANALYSIS
por: Ho, Kam Sing, et al.
Publicado: (2020)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

The Market Access Society launches a new journal
por: Toumi, Mondher
Publicado: (2013)

Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis
por: Zang, Yanxiang, et al.
Publicado: (2020)

“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Therapeutic status of hydroxychloroquine in COVID-19: A review
por: Kaur, Kirandeep, et al.
Publicado: (2020)

Gene therapy randomised clinical trials in Europe – a review paper of methodology and design
por: Ilieva, Krassimira, et al.
Publicado: (2020)

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19
por: Hussain, Nowair, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gss7vfg93fo8om17lantmoljlp